Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Collet

Showing results (261-270 of 376) with videos related to

Pageof 38
Sort By:
European Heart Journal|September 2, 2015
Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trialsJacob A Udell, Marc P Bonaca, Jean-Philippe Collet, et al.
JAMA|October 27, 2011
Clinical, angiographic, and genetic factors associated with early coronary stent thrombosisGuillaume Cayla, Jean-Sébastien Hulot, Stephen A O'Connor, et al.
The American Journal of Cardiology|April 11, 2003
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study)Gilles Montalescot, Claire Bal-dit-Sollier, Daniela Chibedi, et al.
Journal of the American College of Cardiology|October 12, 2019
Long-Term Evolution of Premature Coronary Artery DiseaseJean-Philippe Collet, Michel Zeitouni, Niki Procopi, et al.
Resuscitation|February 19, 2017
Thrombus composition in sudden cardiac death from acute myocardial infarctionJohanne Silvain, Jean-Philippe Collet, Paul Guedeney, et al.
European Heart Journal|July 19, 2021
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapyVictor Aboyans, Rupert Bauersachs, Lucia Mazzolai, et al.
Kardiologia Polska|December 19, 2017
[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.]Marco Valgimigli, Héctor Bueno, Robert A Byrne, et al.
Revista Espanola De Cardiologia (English Ed.)|December 27, 2017
Special article 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTSMarco Valgimigli, Héctor Bueno, Robert A Byrne, et al.
Anaesthesia, Critical Care & Pain Medicine|September 24, 2016
Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015Pierre Albaladejo, Fanny Bonhomme, Normand Blais, et al.
European Journal of Clinical Pharmacology|August 13, 2015
Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE studyJean-Philippe Collet, Jean-Sébastien Hulot, Thomas Cuisset, et al.
Pageof 38

Showing results (261-270 of 376) with videos related to

Sort By:
Pageof 38
European Heart Journal|September 2, 2015
Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trialsJacob A Udell, Marc P Bonaca, Jean-Philippe Collet, et al.
JAMA|October 27, 2011
Clinical, angiographic, and genetic factors associated with early coronary stent thrombosisGuillaume Cayla, Jean-Sébastien Hulot, Stephen A O'Connor, et al.
The American Journal of Cardiology|April 11, 2003
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study)Gilles Montalescot, Claire Bal-dit-Sollier, Daniela Chibedi, et al.
Journal of the American College of Cardiology|October 12, 2019
Long-Term Evolution of Premature Coronary Artery DiseaseJean-Philippe Collet, Michel Zeitouni, Niki Procopi, et al.
Resuscitation|February 19, 2017
Thrombus composition in sudden cardiac death from acute myocardial infarctionJohanne Silvain, Jean-Philippe Collet, Paul Guedeney, et al.
European Heart Journal|July 19, 2021
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapyVictor Aboyans, Rupert Bauersachs, Lucia Mazzolai, et al.
Kardiologia Polska|December 19, 2017
[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.]Marco Valgimigli, Héctor Bueno, Robert A Byrne, et al.
Revista Espanola De Cardiologia (English Ed.)|December 27, 2017
Special article 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTSMarco Valgimigli, Héctor Bueno, Robert A Byrne, et al.
Anaesthesia, Critical Care & Pain Medicine|September 24, 2016
Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015Pierre Albaladejo, Fanny Bonhomme, Normand Blais, et al.
European Journal of Clinical Pharmacology|August 13, 2015
Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE studyJean-Philippe Collet, Jean-Sébastien Hulot, Thomas Cuisset, et al.
Pageof 38